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STUDIES IN A!\fBULATORY CARE
QUALITY ASSESSMENT IN THE
INDIA~

Volume I:

HEALTH SERVICE

Overview Of The Methodology

ORD-SS1871
September 1977

DEPARTMENi OF HEALTH, EDUCATION, AND WELFARE
Office of Research and Development
Indian Health Service
P.O. Box 11340
Tucson, Arizona 85734

ABSTRACT

This report describes a method to assess the quality of ambulatory
health care. A brief review of the literature is presented and the design
decisions basic to the methodology are discussed.
Application of the assessment strategy is completed in stages. First
a set of health problems is selected to represent the major health problems
of the community. A process map (or clinical algorithm) is constructed
for each health problem to describe the expected process of health care.
Process maps specify necessary elements of prevention, diagnosis and
treatment, and they define acceptable health outcomes.
Criteria, which are the benchmarks of effectiveness, are translated
into audit questions (called indicators) which are the actual measures of
. quality. Some indicators are provider-oriented and focus on health
worker performance. Other indicators are patient-oriented and track
individuals through the problem solving process to determine the dis
tribution; continuity and end results of care. Throughout, emphasis is
placed on local staff involvement during all phases of planning and
implementation. Special attention is given to reviewing the operations
of the health system as a whole, as well as the performance of individual
provider s ,.
A pilot study of this methodology is briefly described. Subsequent
reports will present and discuss results from the pilot studies.
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INTIDDucrroN

Recent years have witnessed a growing concern among health
professionals, consumers, medical organizations, and the federal
government for improvements in the quality of health care. The
Joint Commission on Accreditation of Hospitals (JCAR) has been the
major operational quality assurance program since 1952, however
quality assurance activities have been mandated more recently
under two federal laws. The PSRO legislation of 1972 (P. L. 92-603)
directs that medical care evaluations are to be pre-requisites for
reimbursement of costs payable under Medicare and Medicaid.
In 1973 the Health Maintenance Organization (HMO) Act (P. L. 93-222)
required quality assurance activities in all federally supported HMO' s.
Much of the work in quality assurance has been directed toward
inpatient care, while the state-of-the art of ambulatory care quality
assurances remains in its infancy.

Most of the existing quality assurance

mechanisms focus on institutions and examine the performance of
the facility or its providers for those patients who utilize the facility,
rather than examining the quality of the health care received by the
recipient community.
The Indian Health Service (IHS) is charged with the responsibility of
assuring comprehensive health services to defined communities of American
Indian and Alaskan Natives. This responsibility is discharged through
a number of local IHS Service Units designed to function as a comprehensive
health care system. Health services are prOVided through a combination
of inpatient, outpatient, and field activities directed toward the total
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care of the patient in the context of his environment.

Consistent with its

responsibility, each Service Unit directs its effort toward environmental
sanitation, health education, preventive practices, and well patient
surveillance in addition to traditional rodes of acute and chronic care.
In recent years tr..e Tribal and Native organizations have accepted increasing

responsibility in marm:lng and managing seg;rents of its health care program.
As a result, each local health care system has become increasing complex and
existing mechanisms of quality assurance are not entirely adequate to meet
the existmg demands for quality control.
The Office of Research and Development of the Indian P...ealth Service has
been examining methods to assess the quality of care for ambulatory patients
with three basic performance criteria in mind.
easily and economically applied.

First, the method nnlSt be

h1y method that requires additional

resources or significant systems description is lU<ely to be viewed as a
speclaJ: study rather than a routine p.eriodic application of a genuine systems
component.

Second, the method must identify areas of deficiency in health

care and suggest adaptive programs to correct deficiencies.

Any method that

merely atteIq:lts to identify care or llgood" or "bad" is not likely to lead
constructively to improved health care.

Finally, the rrIethod nnlSt vievv health

care from the ccmnunity perspective and examine the health care received by
the commmity rather than focusing entirely on the care provided by any
given facility.
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This report presents an overview of an evolving methodology for
assessing ambulatory patient care cUITently under development in the 00.
The intent is neither to present a comprehensive review of the quality
assurance literature nor to describe an ideal IIEthod that is consistently
followed.

Rather , it offers· same empirically derived guidelines for

examining the quality of ambulatory health care, briefly describes an
extensive field test design, and comments on the feasibility of the approach.
Subsequent reports will describe the results of the field application of the
methodology.
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METHODOLOGIC DESIGN DECISIONS

At the outset it is useful to review the fundamental design

deci~ions

that were made in the design of the quality appraisal method.
1)

What mode of heal th care deliVery is assessed?

The majority of emphasis in quality assessment programs has centered on
hospital care. Methods for specifically evaluating outpatient and field
health care are not as well established. Ambulatory care was chosen
for examination for three reasons.

First, it is the primary mode of

care for patients in the Indian Health Service. Second, it is an appropriate
arena to study patient education, primary education,· screening, early
.diagnosis and treatment, and follow-up.

Third, it is a fertile area for

quality appraisal research.
2) What aspect of quality is measured?
The term" quality" as it pertains to health care, is multi-faceted. In
a classic paper written in 1953, Lee and Tones l identified eight dimensions
of quality care including comprehensiveness and emphasis on prevention.
In later review, Klein

2

categorized 16 aspects of quality such as patient

understanding and continuity of care. More recent discussions have
focused on efficiency3 and acceptability. 4
The principal aspect of quality that is examined in this methodology
is effectiveness; i. e., the ability to solve and prevent health problems.
Effectiveness was selected because it is the sine qua non of quality care.
Other dimensions are examined indirectly.

-5

3) What is the content of the evaluation?
According to

Donabedian~ the content of most health care evaluations

can be divided into three categories: review of structure, process,
and outcome. Appraisal of structure is the least direct method and
involves a review of the" settings and instrumentalities" available for
the provision of health care. Factors such a s organizational policies,
physical plant, and staff qualifications are monitored.

It is assumed

that if the structure is adequate, effective care will be delivered. A
more direct approach is to study the process of care; i. e., what is
done on behalf of patients • Process components includes primary
prevention, screening, diagnostic work-up, treatment, and follow-up.
It is evaluated by determining if necessary services are provided and

if services prOVided are appropriate. The most direct approach to assessing
effectiveness is to measure outcomes, which are the results of care •

•

Several different types of outcomes may be measured. Williamson
identifies diagnostic outcomes which "represent the data required to

determine the need for care, specify therapy and prognosis", and
therapeutic outcomes which "represent the health status of a patient
following treatment. " He also distinguishes between final outcomes
and intermediate outcomes. 6 The final outcome describes a state in
which "the patient· s health status is stabilized at a definable level."
The intermediate outcome is based on pathophysiologic variables
•
which have a direct relationship to the end results, but are measured
prior to stablization.

-6-

S

7
Sanazaro differentiaties between patient end results and process
outcomes. The former refers to changes in signs, symptoms and func
tional capabilities, whi Ie the latter refers to changes in patient
cognition which affects attitudes, comprehension and compliance.
DeckerS describes administrative outcomes including "the utilization
of health services, waiting times and other volumetric measures of
managerial interest" and economic outcomes which specify "costs
generated by services provided."
The content of this evaluation method is limited to measures of
process, diagnostic outcome, and intermediate therapeutic outcome
for representative health problems.

By evaluating process and outcome

simultaneously, it can be directly determined if health problems are
being prevented, diagnosed and solved, and causes of observed
deficiencies can be pinpointed.

Measurement of administrative

economic and process outcomes require specialized data collection
techniques and are not included in this methodology.
4) How is guality assessed?
Two categories of judgments have been described for determining the
quality of care: implicit and explicit. According to Brook 9 , implicit
judgment is based on subjective impressions of the "adequacy of the
process" and the "possible improvability of the outcome." Explicit
judgments are based on objective determinants of quality care which
are documented ahead of time.
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Patient care criteria 'serve as yardsticks for explicit appraisal. IO
These are elerrents against which process and outcome can be measured.

Each

criterion is associated with a performance standard which defines the goals
of acceptable compliance in a defined population, and an indicator which
specifies what information is required to apply the criterion.

For ex.aIIIJle,

consider the criterion, "Pregnant women should have a urinalysis in the first
trimester."

The perfonnance standard adopted by a health system might be

"a minimum of 90% compliance." The resulting indicator asks, ''What percent
of pregnant women have a urinalysis in the first trirrester?"

In this rrethod, patient care criteria and performance standards are
used to make judgments of quality.

The results from this type of approach

tend to be IIDre Uniform than those generated by implicit judgfnents. 9 Also,
explicit judgments can be made by trained para-professionals or computers.
This may reduce evaluation costs and improve feasibility of maintaining
large sample sizes for case review.
5)

From what perspectives are measurem::mts taken?

Two viewpoints are used for patient care appraisal.

In one, attention is

focused on the patient population so that the continuity, distribution, and
end results of care can be measured.

In the other, attention is focused on

the providers so that the quality of their performance can be assessed.
classes of indicators are derived from these perspectives.

Two

Population-based

indicators ask what happens to the patient population; e. g., ''What percent
of the population is
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being screened for hypertension?" or "What percent of infants
received all immunizations by 13 months of age?" They are expressed
in the following units: percent of patient population in compliance
with the criteria for effective care.
Provider-based indicators ask about the delivery of health
services; e.g., "On what percent of laceration follow-up visits does
the provider document wound healing?" They are expressed in the
following units: percent of study encounters or cases in which the
provider complied with criteria.

Both perspectives are incorporated

in this approach.
6) How are the results analyzed?
Results from discreet cases or encounters can either be aggregated
or studied individually. Aggregated data offer a view of the overall
level of care. Isolated results provide a useful starting point for
in-depth case review. Here both methods of data analysis are
employed in order to achieve a balanced picture at the mainstream
of care and the exceptional cases.
In summary, these design decisions were made:
• The object of attention is ambulatory care rather than
hospital care.
• The dimension of quality measured is effectivenes s.
• The content of evaluation includes measures of process and
outcome for a group of repr.es,entative health problems.
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• The yardsticks employed to measure quality are explicit patient
care criteria.
• The perspectives from which measurements are taken are both
patient-based and provider-based .
• Methods of data analysis include aggregation of individual results
and isolation of exceptional results.

\
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OVERVIEW OF THE ASSESSMENT METHODOLOGY

Given the basic design decisions listed above, the development
of a patient care evaluation is carried out in a stepwise manner.

First I

a group of health problems are chosen to represent the major health problems
of the community. Selection is based on the prevalence and potential

s~verity

of the health problem as well as the effectiveness of available strategies.
Kessnerll recommends the following guidelines for selecting
representative health problems:
• Each problem should be relatively well-defined and easy to"'diagnose.
• Each should have a significant I measurable functional impact.
• The techniques of medical management should be well defined for
at least one of the following: prevention, .diagnosis, . treatrrent and
rehabilitation •
• The outcome should vary with the utilization and effectiveness of
care •
• The condition should have a high prevalency rate .
• The epidemiology of the problem should be well understood.
Although there is no' proof of commonalities between tracers and the

. res t of the health problems in the system the use of tracer conditions
I

should not be abandoned. Conditions which are prevalent and have a large
effect on the health care system will be somewhat representative by virtue
of their weight and impact. We I therefore add two criteria to those of
Kessner for selecting tracers.
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• As a group, the diseases being monitored should eover all clinical
functions including primary prevention, screening, diagnostic
evaluation, treatment, follow-up, and well patient surveillance •
• As a group, they should cover a broad spectrum of conditions;
e. g., acute/chronic, adult/pediatric, physical/mental, surgical/
medical, remedial/preventive. Table 1 shows the relationship
between the tracer conditions used in the pilot study to the
clinical functions of health care.
After selecting a set of tracer conditions, each is reviewed in detail
to determine which areas will be examined in the assessment. Graphic
models of the health care process (process maps) are useful in defining
the scope and content of the as ses sment for each tracer.
The development of a process map for iron deficiency an.emia serves
a s a useful example. First, a simple diagram may be drawn to show the
basic sequence of clinical functions (Figure 1). Patients either pass all
the way through the process or drop out. The map in Figure 1 may be
employed for some basic audit designs, but it does have obvious

.

limitations. For one, not all patients who might enter the sequence will
have anemia. These indi'\liduals do no need to pass through distal elements.
Moreover, the map does not distinguish between mass screening and selective
screening, and it wrongly suggests that follow-up is a necessary condition
for a successful outcome. Finally, all pathways on the map lead to dead ends.

-12

If audit planncers desire a more realistic representation of the process,
a revised map like the one in Figure 2 can be constructed. In this example,
new pathways are introduced, and routes are contingent upon diagnostic
and therapeutic results. Also, the new map describes a closed loop
system. Those screened negative are referred for periodic rescreening,
treatment failures are scheduled for additional therapy, and so on. If
the planners want to differentiate between the various causes of iron
deficiency anemia (e. g., pregnancy, dietary deficiencies, chronic blood
loss, etc.), if they want to cover the diagnosis and management of adverse
drug reactions, or if they want to isolate the management of initial episodes
of anemia from subsequent episodes, then additional branches can be
added to the sequence.
There are no absolute rules governing the design of process maps;
however, the following suggestions might be made. First, a conscientious
effort should be made to include all major clinical functions.

Second, the

map should include more closed loop pathways than dead ends. Finally,
branches should be included whenever the potential benefits seem to

.

outweigh projected costs for planning and auditing. The process maps for
each tracer constructed for the pilot study are shown in Figures 2 through
9 (Appendix A) •
Next, a list of problem specific criteria are developed and translated
into indicators which serve as the basis for the audit protocol. The
indicators consist of three types. Population-based indicators express
a percent of the total community which has received a particular health
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service. This class of indicators characterizes the extent to which the
he~lth

care system is meeting the needs of its total patient population.

By tracking specific patient cohorts they describe the continuity, distribution,
and appropriateness of health services received. This measure of system
performance might be reflected by population-based indicators such as:
1.

What percent of the community has been adequately screened
for hypertension?

2•

What percent of infant in the community have been adequately
immunized against poliomyelitis?

3.

What percent of patients diagnosed with otitis media, received
adequate antibiotic therapy?

Provider-based indicators express a percent of contacts between
patients and the health care system in which particular health services
were provided. This class 6f indicator choracterizes the adequacy of health
services provided when patients utilize the health care system, provider
based indicator data can be aggregated to characterize the performance
of individual providers, provider disciplines, or all providers in the
system. This performance measure might be reflected by indicators such
as:
1.

What percent of patient visits due for a screening blood
pressure resulted:in a blood pres sure recording?

2•

What percent of infant visits due for poliomyelitis immunization
resulted in an immunization?
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3. What percent of patient visits including a diagnosis of otitis
media, was an appropriate antibiotic prescribed and a follow
up visit scheduled at an appropriate referral?
Finally, health status indicators expres s the percent of patients for
whom a change in health status has been documented. One should be
cautioned against equ·ating health status indicators with measures of
incidence or prevalence since the latter requires a random sampling of
the population. Health status indicators on the other hand often reflect
change in health status of selected patient group; e. g., only those who
were followed-up.
The process maps of Figures 2 - 9 (Appendix A) show the points in
the process of care where indicators are measured. The indicators are
analogous of s ens ors or probes which monitor the function of complex
machinery. As a group they pinpoint the areas of strength and weakness
in the process of health care.
Some population based indicators are analogous to "flow meters"
and can be constructed in a sequence in order to examin=· the continuity
of care. Referring to a process map, such as the one in Figure 7 of
Appendix A, the patient population can be seen to percolate down through
a variety of pathways.

If flow meter indicators are placed along the major

routes, they will measure the distribution and continuity of health services.
For example, if an indicator is placed at the entrance of the screening
element, the results will show how well screening services ere
distributed among the at-risk population. These indicator sequences
may focus on any of the clinical functions of the health care proces s
-15

and can express "continuity" as a series of conditional probabilities based
on enpirical data.
By examining continuity of care in this way, the assessrrent methodology

can identify discontinuities in health care and distinguish between those
related to provider-behavior and those related to patient utilization of
services.

In general a required health task is completed only when three

basic steps occure.
appropriate provider.

First, there must be contact between the patient and an
Second, the need for that health care task must be

recognized, and finally the task must be performed.

Conventional wisdom

would suggest that making contact with the health care system for services
is generally the responsibility of the patient.

The recognition ftmction is

the shared responsibility of the patient ,who may· refiect need in his chief
conp~aint,

and the provider who reviews the patient's record.

perfonnance of the task is the responsibility of the provider.

Finally, the
The tracers

whose process maps appear as Figure 7, 8, and 9 (Appendix A) employ indicator
sequences designed to examine the continuity of care in this way.
'!he next step in designing an assessment methodology involves defining
criteria for each indicator.

Professional guidance from consultants or

local experts can be solicited to help develop the initial criteria list.
An

exhaustive literature search is often necessary to validate assessment

criteria.

Even if criteria are borrowed from pre-existing criteria lists,

they must be adopted for local circumstances.

This burden can be relieved

by expert consultants who are familiar with the literature.
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In generating cr1teria it is useful to consider the suitability of
criteria for auditing the quality of care. Suitability is a function of
the expected documentation patterns, scientific validity, and potential
constructiveness of the proposed criteria.·
• With respect to documentation, audit specific data, which
are used to determine compliance, should be reliably recorded
in the medical record.

In general, prescriptions, measurements,

lab results and diagnosis are well documented, but historical data I
physical findings (especially negative findings), and educational
treatment plans are not •
• With respect to scientific validity, proposed criteria should be
supported by the results of controlled clinical studies. If this
is not pos sible, consensual support should be obtained from the
local professional community •
• With respect to constructiveness

I

effective corrective action

programs should be available at the local level to as sure compliance
with the proposed criterion.

~t

is a waste of time to measure

elements of care which cannot be changed.
Local providers should be encouraged to inspect and modify the
proposed criteria list. When they are not' given the opportunity to
internalize the cr:iteria which will be used to judge their performance,
the resulting quality assessment effort can be like a major organ graft
that does not take.

Initially, there is a great deal of concern and anxiety,

and then there is a relentless process of rejection. This "host reaction"
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can be prevented by promoting local provider involvement in generating
the assessment criteria.
The indicators and cr:teria generated for each tracer condition in
the pilot study are shown in Tables 3 through 10 of Appendix B.
After the local staff gives fonnal approval to criteria, perfonnance
standards and indicators, the evaluation can begin. The first task is
to identify the material which is to be audited. Usually, charts are
selected on the basis of demographic infonnation or diagnoses.

Claims

forms and disease registries can be used to find the appropriate records.
A sample as small as SO charts is usually adequate to measure most
indicators ,12 however, larger samples will be needed if multiple
statistical breakdown of results are anticipated. If more clinic material
is available than is required for auditing purposes, a representative
sample of records can be chosen using a random method.
Next, the length of the study period is clearly defined. Longer time frames will
provide more audit specific infonnation; however ,. if the study period is too
extensive, specificity is diminished, and the chance for rapid perfonnance
feedback is lost. Evaluations which cover consecutive six to twelve
month periods are practical for most health problems. The study of
acute, seasonal illnesses may require a shorter time frame, and measure
ments may cover non-consecutive study periods.
Chart auditors can be drawn from a wide variety of occupations.
Medical records librarians, clerks with a knowledge of medical tenninology,
laboratory personnel and ccllege students majoring in health related
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professions have all performed well in chart review. 12 Training objectives
include developing an understanding of pertinent medical terminology and
a knowledge of where audit specific information is located in the record.
Prior to the audit, trainees in our program reviewed at least ten charts
per indicator with a qualified health professional.
Two instruments are useful for data collection. The first is a
graphic algorithm or abstractor's map13 which summarizes the elements
upon which judgments are based. Auditors follow the pathways in the map
as a guide to interpretation of data in the medical record. The maps can
also serve as the basis of computer programs for automated evaluation
system ,14 or as the data collection instrument for tracers used to assess
continuity of care. In the pilot study, the data collection instruments for
hypertension, non-deficiency anemia, and urinary tract infections were
patterned closely after the process map.

They are shown in Appendix C.

The second instrument is the data collection form for those tracers for
which provider-based indicators are used. These are included in
AppendiX C.
Large evaluations can be streamlined by conducting the chart review
in stage s • First, he a1th outcome s are as se s sed. If there is compliance with
outcome penormance standards, additional auditing is unneces sary. If
outcome standards are not met, a process audit can be undertaken to
determine where operations have broken down. The initial objective of the
process audit is to confirm that all major clinical functions are present,
I

and that there is continuity between them. If major functions are absent,
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or if continuity is poor, additional auditing is not indicated until
corrective action has been taken. If, on the other hand, major functions
are present, continuity is good, but the outcome is poor, the deficiency
is probably due to inadequate provider perfonnance rather than a general
system failure. A highly specific set of p,rovider-based indicators is
required to study this type of problem.
The validity of the review process should be periodically re-examined.
A health professional other than the original chart auditor should check
10% of the indicator measurements in a single blind study. For our
purposes, a minimum of 80% reproducibility has been considered
adequate.
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THE PILOT STUDY

A pilot study has been implemented using the tracers, criteria,
indicators, and data collection instrument described. Assessment of the
quality of ambulatory care was completed in six Service Units of the
IHS, three rural private practices, and two large Health Maintenance·
Organizations. The results of the assessments will be described in
subsequent reports.
Cost Considerations
The costs of implementing this ambulatory care quality assessment
methodology can be reasonably estimated from experience in the pilot
sites, and are shown in Table 2. In the pilot study there was a single
study design utilized in all the sites and therefore the design costs
could be spread over a total of eleven sites. Likewise an additional
Service Unit that wished to use exactly the same methodology could
do so without investing the manpower specified under the design phase.
However, the manpower requirements for implementation would necessarily
be duplicated in each study site.
In the pilot study, a variety of disciplines were found to serve quite

well as data collectors, including medical records personnel, under
graduate students in health-related studies, medical students, and
nursing personnel. Local manpower availability should probably
dictate who is used as a data collector, and in our experience the
method allows a great deal of flexibility.
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Data Reliability
A test of data reliability was perfonned by using an independent
physician auditor who reexamined a sample of medical record previously
reviewed by each data collector. In all cases there was at least an
85% agreement between the physician standard and the data collector.
Data Validity
A deseIVes mention that this methodology examines the medical
record rather than direct obseIVation of the health care providers
perfonnance. Therefore assessments of the quality of care provided
are in reality assessments of the quality of care as documented in the
medical reocrd. This methodologic problem in 'quality asses sment has
been noted by others 15 ,16 and certainly is not solved by this study
design. The methodology does, however, emphasize the need to
select indicators (and their criteria) which are reliably documented in
the medical record.
A parallel line of reasoning would suggest that essential items
in the process of care should be reliably documented in the medical
record, particularly in health care settings involving several providers.
If the elements of health care incorporated into indicators "are considered
as es sential to good health care, then documentation of those items
in the medical record should also be considered as es sential to good
care. Therefore a quality assurance mechanism that improves the
documentation of such essential items could be considered as
achieving an improvement in the process of health care.

DISCUSSION

An eclectic approach to patient care evaluation has been described.
It is intended for monitoring individual provider performance, the overall

continuity and distribution of services, and impact on patient health
status.

Information is gathered from both population-based and provider-

based perspectives, and judgments rest on explicit criteria. Results
distinguish between health worker deficiencies and health system
deficiencies. Ultimately, the method supports an holistic approach to
quality assurance activities which includes peer review, provider selfassessment and education, management and planning.

Despite~ these

features, a number of important evaluation topics such as acceptability

I

accessibility and affordability, are not given direct consideration. Methods
for assessing these areas are beyond the scope of this paper.
One final caveat is offered. The benefits of patient care appraisal,
for both providers and recipients of health services, are proportional
to the amount of effort and commitment that goes into evaluation efforts.
Our experience suggests that a significant amount of work is required to
achieve a measurable impact. We seriously doubt that half-hearted,
isolated attempts at evaluation will have any long term impact on the
quality of care. Furthermore

I

we feel that audits which do not have the

support of the local staff will almost certainly fail to produce constructive
change. On the other hand, active participation by the local staff in
designing the. evaluation and interpreting the results
.
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I

is the first

step in converting a health services delivery system into a dynamic I
self-correcting system for the prevention and solution of health problems.
Potential rewards are great.
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TABLE 1: Tracer Conditions Used, in Pilot Study, Shown in
Relation to the Clinical Functions of Health Care.

DESIGN PHASE

Quality Assurance Director

10 Man-Days

Physician Consultants

5 Man-Days

Local Physician
(review of criteria &
mdicators)

~

Man-Day (each)

INPIEfllTATION

Physician (training data
collector(s))

2 Man-Days

Data Collectors (data
collection)

10 Man-Days

Data Collectors (data
analysis)

4 Man-Days

Qua.lity Assurance Director

(mterpreting
results)

2 Man-Days

. Quality Assurance Director

(other)

TABIE 2:

2 Man-Days

Estimates of Cost of Irnplerr.enting Po.mbulatory Care
Quality Assurance Methodology m a given site.
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APPENDIX B
TIIDICATORS AND AUDIT CRITERIA

TABlE 3:
PO~TlOtl

STREPTOCOCCAL OISEASE
BASEO PROCESS INDICATORS
COMPUTATION

\
i

i

I!
I

TITLE

OESCRIPTION

STUDY POPUlATIOtl

Selective
Screening
Rate

Wha t percent of fl rs t vis 1ts for
pharyngl tl s recelv~ a throat
culture wi thin two days of the
Initial visit?

All patl ents over the Ige
of 6 years who contacted
a health provl der for
pharyngl tis.

Nuneer of first visits for pharyngitis
In which st~ culture was obtained
divided by total nUllller of visits.

Treatment
Rate

What percent of patients with a
poslt1Ye st~ culture received
all antibiotic within 5 days of
the cul ture date?

All patients over the age
of 6 years who contact~
a heal th pravl der for
pharyngitis.

NUnber .of patients with positive strep
cuI ture resul ts who received any antl
biotic treatment within 5 days of tile
culture result d1Yl<led by the nuneer of
patients with a positive strep culture
result.

Treatmentof-Choice
Rate

IIhat percent of patl ents wi th a
positive strop culture received
either 1.2 lIIU LA 81clll1n
(600.000 lIIU for children less
thall 60 lbs or 9 yrs or lessl.
Oral pen a 10 days
Erythromycin. 10 days within
5 dayS of the culture date?

All patients over the age
of 6 years who contact~
a health provider for
pharyngl tis.

NlRIer of patients receiving LA Blcil1ln
Oral Penicillin or Eryt/lromycln within
5 days dlvl dod by the nuniler of pa
tlents with a positive strep culture.

Unsupported
Treatment
Rate

\/hat percent of patients with
an epISode of pharyllgl tis
recetv~ an antibiotic without
receiving a strep culture?

All patients over the age
of 6 years who contacted
a heal th provider for
pharyngitis.

NUnOer of pharyngitis patients who
recehed an antibiotic dlvld~ by the
nuoOer of patl ents who dt d not receive
a strep throat culture.

I

I

-

TA8LE 4: STREPTOCOCCAL DISEASE
PROVIDER BASED PROCESS INOICATORS
COMPUTATI ON

TITLE

DESCRIPTION

STUDY POPULATION

NARRATIVE

Selectl ve
Screening
Rate

What percent of fl rs t vis I ts for
pharyngitis recehed a throat
cul ture wi thl n two days of the
Initial Visit?

All patients over the age
of 6 years.

Humer of fl rst episodes of
pharyngl tis In whl en strep cuI ture
was obtai n~ dlvl ded by total
numer of episodes.

Trea tIIlen t
Rate

What percent of patients with a
positive strep cultu.... received
an antibiotic within 5 days of
the cu1ture date?

All· patients Over the age
of 6 years.'

Huntler of patl ents wi th pesl tlve
st~ culture I'flults who recehed
any antibiotic treatment 1I1thin 5
days of the culture result divided
by the number of patients with a
positive strep culture.

Treatlllentof-Chotce
Rata

What pelUllt of patients with a
positive strep culture received
el ther 1.2 IIIl LA 81clllln
(600.000 lIIU for children less
than 60 Ibs or 9 yrs or less).
Oral pen a 10 days
Erythrlllll)'cin x 10 days within
5 days of the cul ture date?

All patients over the age
of 6 years.

NlJIlber of patients receiving LA
8lcll11n. Oral Penicillin or
Erythromycin within 5 days dlvld~
by the nuaDer of patients wi th a
positive strep culture.

What percent of patients with an
episOde of pharyngl tis recel ved
an antibiotic without receiving
a strep cuI ture?

All patients over the age
of 6 years.

\
UnsuPllO~

Treatment
Rate

I

I

!

I

HlRIer of patients who received
an antlblotl c dl vi dod by the nuri>er
of patients who dl d not recehe a
strep throat cuI ture.

TA8LE 5: STREPTOCOCCAL DISEASE
HEALTN STATUS (OUTCOI1f) INDICATORS
COMPUT An 0/1
TITLE

DESCRIPTION

STUDY POPUlATION

NARRATIVE

Positive Strep
Culture Rate

What percent of episodes of
pharyngitis which were cultured
result~ In a positive strep culture?

All patients over the age
of 6 years who recelv~ a
throat culture for pharyngitis.

Nulllber of positive s trep cui tures
dlvl ded by number of episodes of
pharyngitis In which a culture was
obtained.

II
I

TABLE 6: RHEUMATIC FEVER PROPHYlAXIS
POPUlATION BASED PROCtSS INDICATORS
COHPIlTATI ON
TITlE

OESCRIPTION

Prophylaxis

What proport1 on of patl@flts were
treated prophylactically during
the study period?

Drug of
Cholca
Rate

STUDY POPULATION

NARRATIVE

All patients on rtleumatlc
fever reg15 try for who'"
registry called for
prophylactic treatment.

Number of patients receiving at
least one prophylactic dose divided
by the tots I study cohort.

What proportion of patients recehed
LA Bicill1n or (If allergic to
penicillin) elt11er Erythl"Oll1Ycln
250 mg QID or SulfadiaZine I grill g.d.?

All patients on rtlewnatlc
fever regis try for whom
registry called for
prophylactic treatment.

NlIlIber of patients receiving
LA B1 cll11 n. ErytllromyCI n or
Sulfadiazine divided by tile totsl
study cohort.

Cohort
Prophyl axi s
Coweraga

What Is the mean percent of the study
year during which tIIa study cohort
was covered prophylactically?

All patients on rtle.....tic
fever regis try for whOlll
reg1stry called for
prophylactic treatment.

Ihamer of weeks each patl@flt was
covered with prophylaxis dlvi ded by
the study cohort times S2 weeks.

Prophylaxis
Coverage
Rate

What Is the . .an percent of the study
year during wh1ch those individuals
receiving prophylaxis were covered
prophylactically?

All patients on rtIeunatlc
fever registry for whOlll
registry called for
prophylactic treatment.

NlIlIbar of weeles' each patient was
covered with prophylaxis divided by
the IlIlIltler of patients receiving
prophylaxis times 52 weeks.

Acute
Rheumati c Fever
Recurrence Rate

What percent of patients suffered
a recurrence of ARF during the study
t i . fr_ (1 year)?

. All patients on rtlewnatic
fever re91 s try for whom
registry called for
prophylactic treatment.

Prophyl axis
Renewal Rate

What percent of visits by post ARF
patients not covered prophylactically
res.ulted In a renewal of prophylaxis?

;

I

\

Rate

Rate

I

I

All patients on rtle_tic
fever registry for whOll
reg1S try ca 11 ed for
prophylactl c treatment.

NlIIiler of patl ents wi th an episode of
acute rtIeumatic fever during the study
year dhl ded by tile study cohort.

,

NUll'ber of patient visits resulting in
a renewal of prophylaxis d1vlded by
the nUlltler of patient vlsl ts not
covered by prophylaxis.

TABLE 7: RHEUMATIC FEVER PROPHYlAltS
PROVIDER-BASED PROCESS INDICATOR
COI'I'UTATlON
TITLE

DESCRIPTION

STUDY POPUlATION

NARRATIVE

Prophyl axis
Renewal
Rate

What percent of visits by post
ARF patients not covered
prophylactically reslilted in a
renewal of pl"Ollhylaxis?

Patients on rtIeumatic fever
re91stry for whom registry
called for prophylactic
treatment.

NlIlIber of patient visits resulting
In a renewal of prophylaxis dhided
by the nUll'ber of patient visits not
covered by prophylaxis.

TABLE B: RHEUMATIC FEVER PROPHYLAXIS
POPUlATION-BASED HEALTH STATUS INDICATOR
COMPUTATION
TITLE

OESCRIPTION

STUUY POPUlATION

NARRATIVE

Acllte
Rh_tlc Fever
Recurrellce Mate

What percent of patients suffered
a recurrence of ARF during tile study
time frlllll8 (1 YHr)7

Patients on rtIelJll\ltlc fever
registry for whOlll registry
called for prophylactic
treatment.

NlIlIber of patients with an epls?O'!.
of KUte rtleUNtlc fever during tile
study year divided by the study cohort.

TABLE 9'

LACERATIONS OF SCALP AHD EXTREIIITIES
POPULATION-BASED PROCESS INDICATORS
COMPUTATION

TITlE

DESCRIPTION

STUDY POPULATION

Wouncl
Descri pti an
Rate

Percent of seal p or extretn1 ty
laceratlon enC1>unters clocumented:
The tlll11 slnce tile laceration.
2 Cause of til. laceratlon. and
3 DeSCM ption of til. wound.

'1

All patl ents over tile age of 6
years who con~acted a ~ealth
provlder for a scalp or extremity
1aceratl on.

Doculllentation
of Extent of
Injury Rate

Percent of sca Ip or extrenr1 ty
1acerati ons wl th cloculll8flted
conslderatlon of bone. nerve
and vascular inwl_nt.

All pati ents over til. age of 6
years who contactecl a ~eal th
provl<ler for a scalp or extretn1ty
laceration.

NLOIi>er of encounters GoCUll'enting if
the wouncl was superficial plus, lf
not superfl cia1. the nUllter of cases
docUll8ntlng sensory. vascular or IIOtor
functlon distal to the laceratlon plus
the nLOli>er of sca1p wouncls where a
skull fracture was considered. ne
above divided by the total nU1tler of
encounters for scalp and extretn1ty
laceratl ons.

Tetanus
Propltyl axl s
Coverage
Rate

Percent of scalp or extretn1 ty
lacerations w~icll had current
tetanus il1lftUlll zati on or where
given tetanus protectlon.

All patlents over the age of 6
years who contacted a hea Ith
provlcler for a scalp or extrenr1ty
laceration.

Nwnber of encounters with current
tetanus IlIIIlJnlzation or nUlllber of
encounters given a tetanus toxol d
cllvlded by the total number of scalp
and extl'l!ftll ty laceration encounters.

Revisit Rate

Percent of patients with suturecl
scalp or extremity laceration by
any health provlcler for any reason
wlthln 5-15 clays of laceration
encounter.

All 'patlents over the age of 6
yea n who contacted a hea 1th
provicler for a scalp or extremHy
laceratlon.

Number of patlents seen for any ....ason
5·15 clays after laceration encounter
cllvided by the total nuriler of sutu·m
sca1p and ext"""l ty lateratl ons.

Percent of patients wl th sutum
sca1p or extrenr1 ty lacerations

All patients over the age of 6
years who contacted a health
provlder for a scalp or extremity
Iacera tl on.

NUll'ber of patlents wi th docUll8ntatlon
of wound healing clivicled by the nUll'ber
of patients with sutured laceratlons.

Follow-up
Rata

wt til doculllefltatlon of wound

heal1ng 5-15 clays after laceration
encounter.

NARRATIVE
. NLOIi>er of encounters doc~ntlng the
tillll. cause and descriptlon of wound
dl vl cled by tile tota J nUllt>er of
encounters for scalp ancl extreorl ty
1aceratlons.

TABlE 10: LACERATIONS OF SCALP AHD EXTREIIITIES
PROVIDER-BASED PROCESS IIIDICATORS
COHMATION
TITlE

OESCRIPTlOlI

STUDY POPULATION

NARRATIVE

Wound
Descri ptl on
Rate

Percent of scalp or extretn1ty
1aceratl on encounters by provl cler
type (III. PHM. CHA. All. PAl that
documented: 1) The slnc. laceratlon.
Z) Cause of laceration. and
3) Description of wound.

All pati ents over the age of 6
yean who contacted a health
provicler for a scalp or extremity
laceratlon.

By provider type n1l1nber·of encounters
doculll8fltlng the tlme, cause and
clescriptlon of wouncl dlvicled by the
total nUllOer of encounters for scalp
and extrenr1ty lacerations.

Doc_tatlon
of Extent of
Injury Rate

By provider type percent of scal p
or extrenr1ty lacerations with
docwnented conslcleratlon of bone.
ne,.,. and vascular invol_t.

All patlents over the age of 6
years wlto contacted a hea 1th
orovlder for a scalp Or extremity
1acerati on.

By provider type number of encounters
docwnentlng If the wouncl WII superfi·
tial plus, If not superflchl. the
nUll'ber of caseS clocullleflting sensory.
vascular or motor function distal to
the laceration plus the nuaeer of
scalp wounds where a skull fractuMl
was considered. The above d1 vi ded by
til. tota I number of encounten for
scalp ancl ext.....lty lacerations.

Tetanus
Prophylaxis
R......al Rate

Percent of patlents who were clue for
tetanus ll11lUnlzatlon and received
tetanus toxold.

All patients over the age of 6
years who contacted a health
provider for a scalp or extretn1ty
laceratlon.

Hwnber of patients wlto recelved
.5 cc aclsorbecl tetanus toxoid dl vicled
by the nLOli>er of patlents who dlcl not
hne a tetanus booster within 5 years.

Follow-up
Rate

All patlents over the age of 6
By provlcler type. percent of patients
yea rs who contactecl a hea1th
with sutured scalp or extretn1ty lacer
provider for a scalp or extremity
ations who ",visl ted provlcler 5·15 clays
after laceration wlth docUlll!lltatlon of
laceration.
wound healing.
HEAlTH STATUS INDICATOR

NUllDer of pa t1 ents whO revl sited a
health provlcler and had a statl!lllent of
wound heallng cl1Yicled by tile total
number of patients in the cohort.

Observed Wound
Infection Rata

Percent of scalp or extf'1!llllty laceration
encounten wIth documentation of wound
lnfectlon wi till n Z weeks.

Number of patients wlth evidence of
wound 1nfeetl on wl thl n 2 weeks Of
laurati on encounter di vi ded by total
nuriler of encounters for scalp and
extrenr1ty laceratlons.

All patlents over the age of 6
years who contactecl a hea Ith
provi cler for a sca Ip or extrenr1 ty
laceration.

TABlE 11:

PRENATAL CARE
POPULATION BASED PROCESS IrlDICATORS

Tnu

DESCRIPTION

STUDY POPUlATION

COMPUT AT! 011

Prenatal
Entry Rata

What proportion of pre<)llant wocnen entered
tile heal th care systeta by the 20th week
of gestation?

WOlIleI\ with a diagnosis of
pregnancy between Oct. I.
1974 and Oct. 1. 1975.

Huriler of WOIIll!ft who made a prenatal
visit at 20 week gestation or less
divi ded by the tota I nuriler of women
who lNIcie a prenatal visit during the
study peri od.

Prenatal
Work-Up
Rate

What proportion of pregnant wo_ had a
VORL." cervical cul ture. pap smear.
eva1 ...tion of rubella status and
cl1nical pe1vill'etry by tile 20th week of
gestation?

Women wi th a diagnosis of
pregnancY between Oct. 1.
1974 and Oct. I. 1975.

Hudler of women who had a VORL.
cervical culture. pap smear. evaluation
of rubelll status and cl1nical pe1Yi
metry by the 20th week of gestation
divided by the total nurOer of WOlllen
who made a prenatal visit during the
study period.

PregnancY
Assessment
Rate

What proportion of pregnant women had
docUlllentation of risk or prognosis of
pregnancy by the 20th week of
gestation?

Women wi th a diagnosis of
pregnancY between Oct. 1.
1974 and Oct. I. 1975.

Number of women who had a statement of
ri sk or prognosis of pregnancy by the
20th week of gestati on divi ded by the
total nuriler of w_ who made a pre
natal visit during the study period."

Wanted.
Unwanted.
Undecl c1ed.
Pregnancy
Assess...nt
Rate

What proporti on of pregnant women had
dOCUIlIIlltatlon of wanted. unwanted. or
undecided pregnancY by tile 13th week
of gestation?

Women wi til a diagnosis of
pregnancy between Oct. 1.
1974 and Oct. 1. 1975.

NurOer of women wi til s tatennt of
pregnancy wanted. unwanted. or unde
c1 ded by the 13th week of 9estatlon
divi ded by the total nunber of women
who had a prenatal visit durin9 tile
study period.

Unwanted
Pre<)IIancy
TAB Rate

What proporti on of
wlth dOCU/I8ntatlon
pregnancy pri or to
gestation received

Women with a diagnosis of
pregnancy between Oct. 1.
1974 and Oct. 1. 1975.

NuaDer of women who received a TAlI
divi ded by the tota I nurOer of women
wl th an unwanted pregnancy pri or to
tile 13th week of gestatlon.

Nutritional
Counseling
Rate

What proportion of patients received
nutritional counseling by the 26th
week of gestation?

Wocnen wi til a diagnos 1s of
pregnancy between Oct. I.
1974 and Oct. 1. 1975.

Nulllber of WOlllel\ who received nutri tion
counseling by tile 25th week of gata
tion divided by the total n""*'er of
women who made a prenatal visit during
th~ -tudv ""rl cd

What proportion of patients recelved
flll11y planning counseling during the
pregnancy prior to discharge following
delivery?

Women wi til a diagnos is of
pregnancy between Oct. 1.
1974 and Oct. 1. 1975.

Nudler of women who received fuily
planning counsel1ng during pregnancy
or prior to discharge foil owl ng
delivery divided by total numer of
women 1n studY cohort.

PregnancY
Induced
Hypertenslon
Screening
Rate

What proportion of patients bed
blood pressure checks at least 3
times In the second and 5 times in
tile thi rd tri mester?

WOIIleIl wi til a diagnosis of
pregnancy between Oct. I.
1974 and Oct. 1. 1975.

Nudler of wo_ ,",,0 had blood pressure
checks at least 3 tlmes In 2nd and
5 tlmes ln 3rd trimester divided by
totaI nurOer of women 1n study cohort
who were seen duri ng thei r 2nd and
3rd trimesters.

PregMncy
Induced
I!ypertens 1on
Recogni ti on
Rate

What proportion of patients with
a diastolic BP greater than 90
recorded during pregnlllcy had a
diagnosis or narrative docUllltnttng
recognition of the abnonlllll
dlastatic blood pressure?

I/oInen with a diagnosis of
pregnancy between Oct. I.
1974 and Oct. 1. 1975.

HUdler of patients with a recorded
dlastol1c blood pressure greater
tIIan 90 who had a diagnosi s or
narrative documenting ACognition
of the abnol"lllli diasto11 c blood
pressure d1Yided by the nlJllDer of
patients wlth a di utol1c blood
pressure ~reater than 90.

Anemia
Screening
Rate

What proportion of patients had a
h_tDCr1t or hemoglobin checkedin the fl rst 20 weeks of gestation?

Women with a diagnosis of

Nuriler of _ n who had a Hgb or Hct
during tIIeir first 20 ..eeks of
gestation divl ded by the n...mer of
......n In the study cohort.

Pregnancy
Monitoring
Rate

What proportion of ;Iregnant_
had the fundal hei gilt measured 3
times in the second and 5 times in
tile third trimester and had the
F1lR docuIIented ona In the second
and 5 ti~ In tile tIIird trimester?

WOIlll!II with a diagnosis of
pregnancy betwftft Oct. I.
1974 and Oct. 1. 1975.

Hudler of women who had tIIei r fundal
hei ght measured 3 times 1n the second
and 5 times In the 3rd trimester and
tile FHR doeIImented once 1n the 2nd
and 5 times in the 3rd trimester
divi ded by the study cohort seen 1n the
2nd and Jrd trimester.

PortpartUIII
Foll""·",,
Rate

What proporti on of women who
delivered were seen within 8
weeks of tile dell very?

Women wi th a dl agnos 15 of
pregnancy between Oct. I.
1974 and Oct. 1. 1975.

N....er of women who we", seen within
8 weeks of de livery dl vi ded by the
nUll'ber of WOftn j n the study cohort
who delivered.

FIlII11y
Planning
Counsel1ng
Rate

,

I

pregnant wocnen
of unwanted
13th wftk of
a TAB?

,

pregnlllcy betwftft Oct. 1.
1974 and Oct. 1. 1975.

j

I

TABLE 12 :

PRENATAl. CARE
PROVIDER BASED PROCESS INDICATORS

TITlE

DESCRIPTION

STIlDY POPUlATION

COMPUTAT!ON

Prenatal
Won-up
Rite

What proportion of pregnant _ _ hid
a VORL. tervital tulture. pap SIIlI!Ir.
and t1 inical pelvillllttry within 2
weeks of the fi rst prenatal visit?

Women with a diagnosis of
preqnanty between Ott. I,
1974 and Oct. 1. 1975.

Nuriler of WOIIIen who had a VORL.
tervital tulture. pap Sllll!ar. and
tlinical peivillll!try within 2 weeks
of the first prenatal visit divided
by the total nuriler of wanen who
made a prenatal visit during the
study peri od.

I
;

Pregnant)"
Assesslllltnt
Rate

What proportion of pregnant women had
doc:umentation of risk or prognosis of
p....9Ranty within 2 weeks of the fi nt
prenatal visit?

Women wi th a diagnos is of
• pregnancy between Oct. 1,
1974 and Oct. I. 1975.

Wanted.
Unwanted.
Ulldecided
Pregnancy
Assesslllltftt
Rate

What proportion of pregnant women had
doc_tation of wlllted. unwanted. or
undecided pregnant)" on the fi rst
prenatal visit?

Women wi th a diaqnosis of
pregnancy between Oct. 1.
1974 and Oct. 1. 1975.

Nurdler of women with a statement of
pre9Rancy waDted. unwanted or undeci did
divided by the total nuriler of women
I
who made a prenatal visit during the
study peri od.

Unwanted
Pregnanty
Counseling
Rate

What proportion of preqnant women
wi th unwanted or undeci ded pregnanty
dotumented on fi rs t vis It recei ved
counsellng within two weeks after
first prenatal visit?

Women with a diagnosis of
pregnanty.between Oct. 1.
1974 and OCt. 1. 1975.

Nuriler of wollll!n wi th unwanted or
undeci ded pregnancy who received an
explanation of options within 2 weeks
of first prenatal visit divided by the
nuntler of women with a statement
of unwanted or uncietided pregnancy on
fi rst prenatal visit.

Anetria
Screening
Rate

What proportion of pre9Rant women
had a h_tocrit or h....glollin
checked within 2 weeks of the first
pnonatal visit?

WOlMn with a diagnosis of
pregnancy between Oct. 1.
1974 and Oct. 1. 1975.

Nuriler of women wi th an Hgb or Hct
within 2 weeks of first prenatal visit
divided by the total nllllber of women
who lI\Ide a prenatal visit during the
study period.

Pregnancy
Monitoring
Ra·te

What proportion of visits IlIIde
after the prenatal evaluation
resulted In documentation of fundal
height?

Women wi th a diagnos Is of
pregnant)" between Oct. 1.
1974 and Oct. 1. 1975.

Number of vis i ts made after the
prenatal evaluation with documented
fundal height divided by the nuriler of
vi si ts lI\Ide by the study cohort.

IlonIn wi th a diagnosis of
pregnancy between Oct. 1.
1974 and Oct. 1. 1975.

NlIlIber of vlsi ts In 2nd and Jrd
trillltSters with retorded blood
pressure divided by the total
number of visits In the 2nd and
Jrd triNSters by the study
population.

Women wi th a diagnos is of
pregnanty between Ott. 1.
1974 and Oct. 1. 1975.

Nu.r of visits with a recorded
diastollc BP greater than 90 with
I diagnosis or narratl.,. dotumenti ng
recognition of the abnol'1Nl diastolic
blood pressure divided by the number
of patients with diastolit BP greater
than 90.

!
Pregnancy
IndUced
Hypertension
Sc:reening
Rate
Abnol'lllli
BP Retogni ti on
Rate

I
r

I

I

What proporti on of vi sits made by
p....9Rant WOlllell in the second and
thi rd trillll!ster resulted in a
dot_ted blood pressu.... recording?

What proportion of visits with a
recorded diastolic BP gruter than
90 hid a recorded diagnosis or narrative
dot_ting recognition of the abnormal
BP?

,

Nurdler of women who had a statement
of risk or prognosis of pregnancy
within 2 weeks of ffnt p....natal
visit divided by the total nuriler of
w_ who lI\Ide a prenatal visit
during the study period.

TABLE 13:

PRENATAL CARE
POPULATION BASED HEAlTH STATUS IrlDICATORS

TITlE

DESCRIPTION

STUDY POPUlATION

COM!'UTATION

Ho"..1 Birth
Weight Rate

Percent of pregnancIes resul tlng In a
bll'th wei ght between 5 I bs 8 0% and
9 lbs.

Newborns of women dl agnosed as
pregnant between Oct. I, 1974
and Oct. I, 1975.

Humer of nMorns wI th a bl rth weI ght
between 5 Ibs 8 0% and 9 Ibs divided
by tile total numer of newbOMlS in the
study populatIon.

Acceptable
1 Minute
Apgor Rate

Percent of pregnancIes resulting in
an I nfant wI th an All9ar 7 or greater.

Newborns of women dl agnosed as
pregnant between Oct. I, 1974
and Oct. I, 1975.

Hum.r of newborns wi th a one 1111 nute
Apgar score 7 or greater divided by
tile total nuniler of newborns In the
study population.

Pregnancy
Induced
Hypertens 1on

Percent of ~regnancles wI th doc~ntatlon of pregnancy induced hYl'el'tenslon
or dlastollc 8P greater than 90 lID Kg.

Women dIagnosed as pregnant
between Oct. I, 1974 and Oct. 1 ,
1975.

NIIItl.r of wOlllen ", th pregnancy Induced
hypertensIon or dhstollc 8P greater
than gO dl rl cled by the tota 1 stud)'
population.

Gestat I ona I
Dlitleties
Rate

Percent of preraancles "Ith docUlllllnta'
tlon of gestat onal dlabeties.

1I00000n dhgnOSed as pregnant
between Oct. I, 1974 and Oct. 1,
1975.

NIJItl.r of w _ wi th doc....nted
gestational dlabeties dlrlded by the
total stud)' population.

"1nl_
EstlNte of
Prenlence of
Anula In
Pregnancy

Percent of pregnanel es "I th documenta
tlon of aneona.

1I0men dllgnosed as pregnant
between Oct. I. 1974 and Oct. I.
1975.

rlumer of IOClI'8n "I th doc....ented a_I a
dlrlded by the total nudy population.

Opel'athe
Qelhery
Rate

Percent of pregnancl es te..,1 nating ,,1th
operathe dell very.

l/OIIlltn dl agnosed as pregnant
between Oct. I, 1974 and Oct. I,
1975.

Hudler of pregnancllOS te..,lnatlng "lth
operathe de11 very dhl ded by the total
study population.

TAB FUI1ly
Planning Rate

Percent of "omen "i th TAB who received
family planning "ithln 4-8 weeks after
TAB.

Wilmen di agnosed as pregnant
between Oct. I. 1974 and Oct. I.
1975.

rtunlel' of "omen "ho received falll1ly
planning 4-8 "eeks after TAB divided by
the total nuaeel' of TAB In the study
population.

Post Pal'tllllS
FllIily
PI annlng
Rate

Percent of pregnant women who del hered
who "egan family pleMln9 within 4-8
weeks of delivery.

Women diagnosed as pregnant
between OCt. I, 1974 and Oct. I,
1975.

Hunilel' of WOGll!n who began 'amlly
planning 4-8 ....ks post pal'tUlll
dhlded by the total nudlel' of
del hel'l es.
fluJlilel' Of ~n "ho ~lned Tree
of pregnancy one year after de
llvery divided by total nudlel' of
w..-..- ...h" . rl; 1i v"red.

Ra~

R_Ined Free Of
Pregnancy For One
Year Rate

Percent of _
that remained free
pregnllJlcy one year.

0'

Women dhgnosed as pregnant
bet)oeen OCt. I. 1974 and OCt. 1.
1975.

TABl£ 14:

IHFAIlT CARE
POPULATlOII BASED PROCESS IIIDICATORS

TITlE

DESCRIPTIOII

STUDY POP\lLATION

COMPUTATlON

Inl tl al
Feeding
Instruction

What proportion of Infants' mothers
received diet or feeding Instruction
prior to discharge after de11very?

Women who de 11 vered between
July I, 1975 and July I, 1976.

IIUIIGer of women who reeel ved nutrl tl on
feeding counse11ng prior to discharge
after de11very divided by nUIIGer of
live deliveries In study population.

Inl ttal
Infant Care
Counseling
Rate

What proportion of Infants' mothers
received Instructions on general
topics of Infant care prior to
discharge after de 11 very?

Wooen "ho de11vered between
July 1, 1975 and July 1, 1976.

NUIIOer of women who recel ved Inhnt
care counseling prior to discharge
after delivery divided by the n!..tler
of 11ve del1veries In study population.

Growth
Monitoring
Rate

What proportion of Infants had "el ght
and length recorded at least 3 times
In fl rst 6 _ths and at least 2 times
In s_d 7 _ths of l1fe?

. Bl rths between Aug. I , 1974 and
Aug. 1, 1975 (~st be 13 mo.
old betwe"" 911175 and 911/76).

Nuriler of Infants "lth weight and
1ength recorded 3 ti mes 1n fl rs t 6
months and 2 times In second 7 months
of 11 fe dl vi ded by the tota1 nUllCler
In the study population.

What proportion of Infants had
documented statellltnts of developlll!nta I
milestones at least 4 times In the
first 6 _ths and at least 3 times
. In the second 7 months of llfe1

Births between Aug. 1, 1974 and
Aug. I, 1975 (IIIISt be 13 mo.
old between 911/75 and 911/76).

Nuriler of Infants with develol/ll!tltal
history at least 4 times In the fl rst
6 months and at least 3 times III
second 7 months of 11fe divl ded by
the total nUl'lber In the study popula
tion.

Development
Monitoring
Rate

Diet
Monitoring
Rate

What proportion of Infants had
docUQlntatlon of dietary Intake at
least 4 tines In the first 6 IIlOIlthS
and at least 3 times In the second
7 months of l1fe1

Bl rths between Aug. 1, 1974 and
Aug. 1, 1975 (""st be 13 1IllI.
old between 9/1/75 and 9/1/76).

Nuuoer of Infants "lth diet history
at least 4 times in the 11 rst 6 months
and 3 times In the second 7 IIllIntlls of
life divided by the total n!..tler In
the study population.

IlIIllWIl uti on
Rate

What propdrtlon of Infants had recel ved
3 DPT. 2 OPV. a measles and a rubella
1....... lzatlon by age 13 IIllInths1

Births between Aug. 1, 1974 and
Aug. 1. 1975 (must be 13 mo.
old between 9/1175 and 911/76).

HUIIlber of 1nfants ,",,0 recei ved 3 OPT,
2 OPY, a l1ll!asles and rubella Ill111U11iza
tion by age 13 months divided by total
nunaer In study population.

Inhnt Care
Counseling
Rate

What proportion of infants' IIlllthers
received counseling In topiC1 of
Infant care at least once In first
six IllOftths and once In second 7
monttls· of 11fe1

Bl rths between Aug. 1, 1974 and
Aug. 1, 1975 (IIIlSt be 13 mo.
old between 9/1/75 3nd 9/1/76).

Number of mothers receiving Infant
care counseli IMJ once In fl rs t 6 IIlllnths
and once In second 7 months divl ded
by total nllliler In study population.

Anlllrla
Screening
Rate

What proportion of Infants had a
HCt/Hgb recorded 1n second 7 months
of l1fe1

BI rths between Aug. 1, ;974 and
Aug. 1. 1976 (III1St be 13 010.
old between 9/1/75 and 9/1/76).

IIl11'1ber of Infants with an Hct or Hgb
reconled In the second 7 _ths of
I I fl dl vi did by the tota I nuri>er of
Infants In the study population.

What proportion of Infants sc~ed
for antll1a were screened positive
(Hgb less than 12 gift. or IIct less
than 31")1

Births between Aug. 1, 1974 and
Au9. 1,1975 (must be 1311ll1.
old betwel!ft 9/1/75 and 9/1/76).

Number of Infants "I th a Hct 1ISS than
37S or 11gb 1ess than 12 !lIII. between
6 IIIOlIthS and 13 _thS of l1fe divided
by thl n!..tler of 1nfants ,,110 received
a Hct or Hgb between 6 and 13 lIlOlIthS
of Iffe.

TB ScreenilMJ
Rate

\/hat proportion of Infants had a
PPD or TIne test 'n the second 7
_ths of 11 fe 1

Births between Aug. I, 1974 and
Aug. 1, 1975 (IIlUSt be 13 mo.
old between 9/1175 and 911176).

rllll'lber of 1nfants "I th a PPD or 11 ne
test recorded I n the second 7 IIlOIlthS
of 11ft divided by thl total nuoeer
of Infants In the study pOllUlat1on.

Hlp Dysplasia
Screening
Rate

What proportion of Infants had
dOcuIll!ntatlon of specific hlp
exillll In their first 6 months of
l1fe1

Bl rths between Aug. I. 1974 and
Aug. I, 1915 (must be 13 mo.
old between 9/1/15 and 9/1/16).

IIU1lber of Infants w1th a hip eXIII In
the fl rs t e man ths of 11 fe d1 vi ded by
the total nUllCler of Infants in the
study popuiatlon.

Aneall a
Sc~lng

Yield
Rate

I

Tallie 15:

INFAIfT CARE
PROYJDER BASED PROCESS INDICATDRS

TItlE

OESCRIPTION

STUDY POPUlATION

COMPUTATION

Growth
Monitoring
Rate

WIlat proportion of Ylslts hid "'I~
IIld lengtll I'9COrded during flnt 3
months of I1fel

Births between 8/1/74 IIld
8/1175.

Naner of Yis I ts wi th recorded
wight and 1engtll during fiNt
13 months of 11 fe dM ded by the
total nuaeer of Ylslts ...de by the
study population.

OPT

W1lIt proportion of ylsits ...de when
III inflllt was due for a DPT IlIIIIUIllza
tlon was the 1.....lzatlon glvenl

Births betWtlen 8/1/74 lIlii
8/1/75.

Nuriler of vi sits lIIIIde w11lle overdue
for OPT IIld received a OPT divided
by total nuaeer of overdue visl ts.

What proportion of yis I ts had doc_ta
tlon of recent dietary Intakel

Births be~ 8/1174 and
8/1/75.

lluaeer of ylslts with ~tatlon
. of diet history divided by total
nlllDer of Yis Its llllde by study pop
ulation.

llIIIIUIllzatlon
Rate
Diet
It1story
Rate

TABlE 16:

INFNlT CARE
POPULATIDIl BASfD HEAlTH STATUS INDICATORS

TInE

DESCRIPTION

STUDY POPUlATION

COHPl1TATIOIl

Adequate
Growth
Rate ..

Wlllt proportion of Infants were between
the 10th and 90tII percentiles for hel gilt
and weigllt at approlliJllUly 1 year of agel

81rths between 8/1/74 IIld
8/1/75.

Nuriler of Infants with helgllt and
weight b e _ 10th IIld 90th percen
tiles at 1 year of age divided by
nuriler of Infants In study sllllP1e
wltll recorded weight and height at
approlllllllUly 1 year of age.

Birth
Depression
Rate

WIlat proportion of Infants hid III Apgar
Score less than 6 at 1 IItnute or less
thlll 8 at 5 lit nutes1

81rths betweetl 8/1/74 and
8/1/75.

NUIIOer of I nfants wi th III Apgar Score
1ISS thlll 6 at I lit nute or less than
8 at 5 mnutes divided by the total
nuaeer of Infants In the study
popul atlon.

Total
h_nlzatlon
Rite

What proportlOll of I nflllts hid recei ved
JDPT.ZDPV. IIIIIISIIS IIld a Nbella
i_izatton by age 13 _tIIs1

81 rths between 8/1/74 and
8/1/75.

NUlllber of Infants who received 3 OPT.
I DPV. a ..ules IIld a Nbella llIIIIUI'Il
zation by 1ge 13 _ths di vi ded by
total nllllber In study population.

DPT • OPY
1-.1zation
Rate

What proportion of infants received
3 OPT and 2 OPY by age 13 _ths?

Births betWtlen 8/1/74 IIld
8/1175.

NlIIDer of infants who received 3 DPT
and 2 OPY by age 13 IIlOI\ths dl vided
by the nuaeer of Inflllts In the study
cohort.

Mlnl_
EstlllIte
PreYllance
of AneII1a

What proportion of Infants hid
clocu_tatlon of I positive HIJb
(less t111l1 12 gill) or Hct (less
ttllII 371) between 6 _tIIs IIld
13 _ttls of agel

Births between 8/1/74 and
8/1175.

NlIIIber of Inf;Pii..f1 til I NgD IISI tIIen
11
!PI 01' IIct
tUn 371 _ - . .
• _dis I" 13
of 191 divided
by ttle nudler of I nflllts In the study
coIlort.

Infant
Nutrition
and Feedin9
Instruction
Rate

What proportion of Infant mttlers
received Inflllt nutrition and feeding
instJ'ucttons prior to discha~ f.
tile hosPltll?

WOIIIIn who deII vered b e _
July I. 1975 IIld July I. 1976.

NUlDer of Infant IIIOthers who received
~tatlon of infant nutrition and
feeding InstNction prior to dischl~
frclll the hospital divided by ttle
nlIIIber of Inflllts In ttle study cohort.

Breut
FH4lng
Rate

What proportion of Infant IIIOthers
wre dlsclll'"'Jed fro. the hospl tal
breast feed I ngl

W- who dellYered between
July 1. 1975 IIld July 1. 1976.

IIl111ber of Infant lIIOthers discharged
fro. the hospital after delivery with
~tatlon of breast feeding divided
by tile nlllDer of Inflllt IIIlltllen.

Inflllt
Care
CCWlSellng
Rate

What proportion of Inflllt mt/len
received Infant care coWl.. lIng
prior to d1scha~ f~ tile hospitall

W_ who deII vered b e _
July I. 1975 and July I. 1976.

Naner of Infant IIIItllers who received
doc_tation of Infant care counseling
prior to discllarge Ifter delivery
divided by the nllllber of Infant IIDthen

_*

-

.

TABLE 17:

!'

.

,"'

SYSTEM PERFORMANCE' .FOR :'.
HYPERTENSION. SCREEN ItW" .
(Popul~tion-B~s~dlridic~id~s)
.

INDICATOR
Screening Contact
Rate
Screening Rate

Abnormal Screening
Recognition Rate

Abnormal Screening

Rescreening Rate

Screening Yield

.

.;. ',: ';,;. :.',!';

DESCRIPTION
STUDY POPULATION
Percent of population who made co~ All persons in the
tact with the health care system
patient population
between the ages of.
at least once within the three
40-60 years.
year time frame (1/1/74-1/1/77) •
Percent of patients making contact All persons in the
who had their blood pressure re
patient population
corded at least once (in the
between the ages of
absence of trauma, pregnancy, in
40-60 years.
toxication, or under the influence
of medication known to elevate
blood pressure) •
Percent of patients with a posiAl! persons in the .
tive BP screen (diastolic BP >90
patient population
for whom there was any statement
between the ages of
40-60 years ..
or action indicating recognition
of the abnormal result on that
,
visit.
Percent of patients with abnormal
All persons in the
screening BP who made contact with patient population
the system within 6 weeks of the
. between the ages of
abnormal BP.
40-60 years.
Percent of patients making contact All persons in the
patient population
ho had a blood pressure recorded
between the ages of
within 6 weeks of the original
40-60 years.
abnormal result.
Percent of patients screened
during the time frame, who had one
or more diastolic blood pressure
readinqs above 90mm Hq.

All persons in the
patient population ..
between the: ages of
40-60 years.

!",

COMPUTATION
Number of persons who made contact
with the helath system at least
once during the time frame, divid
ed by the total study population.
Number of persons who had at least
one blood pressure recorded, di
'vided by the number of persons
contacting the health care system.

Number of patients for whom there
was documentation of recognition,
divided by the number of persons
with an abnormal blood pressure.
Number of patients making contact
with the health care system with
in 6 weeks, divided by the number
of persons with an abnormal BP.
. Number of patients with an addi~
tional blood pressure recorded
within 6 weeks, divided by the
number of persons who re-contacted
the health care system.
Number of persons with on or more
abnormal blood pressures, divided
by the number of persons who were
. screened during the time frame.

.f

:!

'fABLE 10:

S'iS'fEM PEHF'OHMAl-lCg FOR
IRON DEFICIENCY 1\NEr-IIA
(Population-Bused Indicators)

INDICATOR
Contact for Screening
Rate

Screening Rate

DESCRIPTION
Percent of infants and prenatal
patients who made contact with the
health care system when they re
quired screening for anemia.
(Percent of infants contacting the
system between ag.e 6-13 mos.
Percent of prenatal patients con
tacting the system by 20th week of
gestation.)
Percent of infants and prenata1s
making contact for screening, who
had a hematocrit and/or hemog10bi~

Evaluation Contact
Rate

Percent of patients screened posi
tive for anemia (Hct <33 and/or
Hgb <11) who made contact with the
system within 3 weeks after posi
tive screening.

Abnormal Screening
Recognition Rate

Percent of patients making contact
for whom there is any statement or
action indicating recognition of
the abnormal result.

Diagnostic Work-Up
Rate

Percent of patients with recogni
tion of abnormal reSUlt, for whom
any statement of dietary intake
was documented.

STUDY POPULATION .
Women with diagnosis
of pregnancy between
10/1/74-10/1/75.
Infants born between
8/1/74 and 8/+/75.

COMPUTATION
Number of persons who contacted
the health care system during the
time frame for screening, divided
by the total study sample.

Women with diagnosis
of pregnancy between
10/1/74-10/1/75.
Infants born between
8/1/74 and 8/1/75.
Patients with a Hct
<33 or Hgb <11 between
1/1/76 & 1/1/77 who do
not have neoplastic
dise~se, acute or
chronic blood loss, or
an anemia previously
diagnosed as other
than iron deficiency.
Patients with a Hct
<33 or Hgb <11 between
1/1/76 & 1/1/77 who do
not have neoplastio
disease, acute o~
chronic blood loss, or
an anemia previously ,
diagnosed as other
than iron deficiency~
Patients with a Hct
<33 or Hgb <11 between
1/1/76 & 1/1/77 who do
not have neoplastic··
disease, acute or
chronic blood loss, or
an anemia previously
diagnosed as other •.
than iron deficiency.

Number of persons who were screen
ed, divided by the number of
persons who made contact with the
system during the time they were
due for screening.
Number of patients who made con
tact with the system within 3
weeks after the positive screening
result, divided by the number of
persons with a positive screening
result.

Number of patients for whom there
is evidence of recognition, di
vided by the number of patients
contacting the health care system.

Number of patients with documenta
tion of dietary intake, divided by
the number of patients contacting
the health care system.

TABLE 10:
INDICATOR
'freatmcnt Rate

Percent
tion of
started
week of

DESCRIPTION
of patients with recogni
abnormal result, who were
on iron therapy within 1
diagnosis.

Contact Rate for
Follow-Up

Percent of patients begun on
therapy who made contact with the
health care system within 3-6
weeks after iron therapy was in
stituted.

Follow-Up Recognition
Rate

Percent of patients contacting the
system 3-6 weeks after therapy
started, for whom there was any
statement or action indicating the
need for follow-up.

Follow-Up Rate

Percent of patients with recogni
tion of the need for follow-up who
received a hemoglobin and/or hema
tocrit within 3-6 weeks after in
stitution of iron therapy.

Screening Yield

Percent of infants and prenatal
patients screened for anemia who
had a Hgb <11 and/or Hct <33.

(Continued)·

STUDY POPULATION
Patients with a Hct
<33 or Ugb <11 between
1/1/76 & 1/1/77 who do
not have neoplastic
disease, acute or
chronic blood loss, or
an anemia previously
diagnosed as other
than iron deficiency.
Patients with a Hct
<33 or Hgb <11 between
1/1/76 & 1/1/77 who do
not have neoplastic
disease, acute or
chronic blood loss, or
an anemia previously
diagnosed as other
than iron deficiency.
Patients with a Hct
<33 or Hgb <11 between
1/1/76 & 1/1/77 who do
not have neoplastic
disease, acute or
chronic blood loss,or
an anemia previously
diagnosed as other
than iron deficiency.
Patients with a Hct'
<33 or Hgb <11 between
1/1/76 & 1/1/77 who do
not have neoplastic
disease, acute or
chronic blood loss, or
an anemia previously'
diagnosed as other
than iron deficiency.
Women with diagnosis
of pregnancy between
10/1/74-10/1/75.
Infants born between
8/1/74 and 8/1/75.

COMPUTATION
Number of patients started on iron
therapy, divided by number of
patients with documentation of
recognition of abnormal result.

Number of patients on therapy who
contacted system, divided by num
ber of patients who began iron
therapy.

Number of patients with evidence
of recognition of need for follow
up, divided by number of patients
who contacted the system 3-6 weeks
after therapy started.

Number of patients who had a fol
low-up Hct or Hgb, divided by the
number of patients with recogni
tion of the need for follow-up.

Number of infants and prenatal
patients with a Hgb <11 and/or
Hct <33, divided by number of
patients screened.

TABLE 18:
INDICATOR
Resolution of Anemia
Documentation Rate

"

Ill' .

(Con'tinued!r:.<: ",:';'" "

,:,,<,I!':.;;' "::',',::'

DESCRIPT,ION
STUDY POPULATION: '
Percent of patients with a repeat ' Women with diagnosis
Hct and/or Hgb 3-6 weeks after
of pregnancy between
therapy started, which resulted in 10/1/74-10/1/75.
Infants born between
a Hct >33 and/or Hgb >11.
8/1/74 and 8/1/75.

COMPUTATION
Number of patients with a repeat
Hct >33 and/or Hgb >11, divided
by the number of patients with a
repeat Hct or Hgb.

SYSTEM PERFORMANCE FOR
'URINARY TRACT INFECTIONS
(Population-Based Indicators) ,

TABLE 19:
!

INDICATOR
Evaluation Contact
Rate

DESCRIPTION
Percent of patients with a positive
urine culture (>100,000 organisms)
who made contact with the health
care system within 2 weeks of
positive culture.

Abnormal Screening
Recognition Rate

Percent of patients making contact
within 2 weeks, who had any state
ment or action indicating that
positive culture was recognized.

Diagnostic Evaluation
Rate

Percent of patients with recogni
tion of positive culture, who had
documentation of the history,
description of symptoms, tempera
ture, and palpation of the abdomen.

Treatment Rate

Percent of patients with recogni
tion of positive culture, who were
placed on an appropriate antibio
tic therapy within 2 weeks of
positive culture. (Soluble
sulfonamide, ampicillin, tetra
chine, or nitrofurantion)

Follow-Up Contact
Rate

Percent of patients treated who
made contact with the health care
system within 1-4 weeks after the
treatment was started.

STUDY POPULATION
Patients with a urine
culture >100,000 or
ganisms between 1/1/76
and 1/1/77. Excludes
patients with chroni~
or recurrent UTI or
known abnormal anatomy
of urinary tract.
Patients with a urine
culture >100,000 or
ganisms between 1/1/76
and 1/1/77. Excludes
patients with chronic
or recurrent UTI or
known abnormal anatomy
or urinary tract.
Patients with a urine
culture >100,000 or
ganisms between 1/1/76
and 1/1/77. Excludes
patients with 'chronic
or recurrent UTI or '
known abnormal anatomy
or urinary tract.
Patients with a urine
culture >100,000 or-:
ganisms between 1/1/76
and 1/1/77. Excludes
patients with chronic
or recurrent UTI or
,known abnormal anatomy
or urinary tract.
Patients with a urine
culture >100,000 or
ganisms between 1/1/76
and 1/1/77. Excludes
patients with chronic
or recurrent UTI or
known abnormal anatomy
or urinary tract.

COMPUTATION
Number of patients with positive
urine 'culture who made contact
with the system, divided by the
total study cohort.

'Number of patients with recogni
tion of abnormal result, divided
by the number of patients who con
tacted the system.

Number of patients receiving dia
gnostic work-up, divided by the
number of patients with recogni
tion of the need for a work-up.

Number of patients placed on anti
biotic therapy, divided by the
number of patients with recogni
tion of the abnormal result.

Number of patients who recontacted
'the system, divided by the number
of patients who were started on
therapy.

TABLE 19:
INDICATOR
Follow-Up Recognition
Rate

Follow-Up Rate

Negative Reculture
Rate

DESCRIPTION
Percent of patients making contact
for whom there was any statement
of action indicating recognition
of the need for follow-up~

(Continued)

I'

STUDY POPULATION
COMPUTATION
Patients with a urine
Number of patients with document
ation of recognition of the need
culture >100,000 or
ganisms between 1/1/76 for follow-up, divided by the num
ber of patients who made contact
and 1/1/77. Excludes
with the system.
patients with chronic
or recurrent UTI or
known abnormal anatomy
or urinary tract.
Percent of patients with recogni
Patients with a urine
Number of patients who had a re
tion of the need for follow-up who culture >100,000 or
peat urine culture, divided by the
received a urine culture within
ganisms between 1/1/76 number of patients with recogni
1-4 weeks after 'treatment started. and 1/1/77. Excludes
tion of the need for follow-up.
patients with chronic'
or recurrent UTI or
known abnormal anatomy
or urinary tract.
Percent of patients treated and
Patients with a urine
Number of patients with a normal
followed-up who had a repeat urine culture >100,000 or
repeat culture, divided by the
culture resulting in <100,000
ganisms between 1/1/76 number of patients who had a re
organisms.
peat culture.
and 1/1/77. Excludes
patients with chronic
or recurrent UTI or
known abnormal anatomy
or urinary tract.
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APPENDIX C
DATA COLIEc:rION lliSl'RUMENTs

Sells 11:',- .-- ,- -LLLJ

III

f5
eJ
,2
.,;

13-,

I

I

I

I

I

I

Pisinimo 14-,

I

I

!

I I

I

16-.

I

I

I

I

I

SR

!ao

lID

u

~ I(cc 1-7)

Ab
LC
LMP

[j]

FIRST VISIT

BIRTIl DATE
(cc 45-50)

Firs~

Last

INFANT'S NAME

~Qic;Q

BIRTH DATE
(cc 51-56)
(cc 57-58)

COMM. OF RESIDENCE

OB DATA (Record TYPe 03
cc: S:44)
GR
PAR

I

PATIENT'S NAME

GJ~

Provider TYPe/Site
Week of Gestation
No. of visits btv.
LMP & first visit
History
HGB
HCT
SEROLOGY
TYPe/Rh
Blood clucose
MGTT. or GTT
Rubella ti tre
UA
Pap smear
GC culture
Tine/PPD·
CXR
Breast exam
Fundescopic
Cardiac exam
Pelvimetry

B

Statement of Pregnancy
l-vanted
2-unwanted
3-undec1ded
4-no statement
It unwanted or
undecided
l-counseling
2-TAB discussed
3-TAB planned
4-TAB done

0

(cc 59)

t:J (cc

60)

rn 00 (cc 61)

Statement of risk or
prognosis or pregnancy

Documented on admission:
Onset of labor
Time of show
Bleeding
StatuB of membranes
Length of pregnancy
EFW (es.t fetal vt.)
Contraction interval
Contraction length
Contraction

FHR

It TAB done - vas pt.

on family planning
in 4 veeks

LABOR AND DELIVERY
(Record Type 04-cc8-32)

Position
Station
Cervical
BP
VA

effac~ment

o

Method of Delivery:
l-Spont vag
2-Induced vag
3-Operlltive
Cooplicaticna cr ..thcr,~

Prior to discharge:
Family planning
discussed
Method
planned

Ulst

wMO.

CiJ
GJ
DAY
YR.

Pain
DischarBe
Dysuria
Bleeding
Breast exam
Episiorrhaphy
Uterus
BP
UA

Weight
Family planning
discussed
Method planned _---.-::--,
Started
W N
Breast feeding
discussed
Infant care
counseling

[i3

0
0

Newborn (cc 48-64)

APGAR l'
APGAR 5'

_~

wOO

COL t Ec. TID",'

PEEN Ai/\ L..

IN S~UI\1~A1"
t:..Ai?E )

1]

-------ltj

o

Fe£.

(:=:::J

0-1

I

I

I

I

I

Newborn care:

Post Partum (cc 31-41)

B.W.
Length

PHASE

INFANT'S RECORD NO.

Newborn complications:

Started
Infant care counseling
Nutrition/Feeding
.counseling
Breas t feeding
started

(OATA

First

Silver nitrate
drops in eyes
0.5-1.0 of VITK,
1M
Temp recorded
daily vhile in
nursery
Statement of
risk or pro
gnosis

D
c=J

0
c==J

I

J RECORD

TYPE 50

CODES-Provider type/site
I-Sells OPD
2-MCH Clinic
3-Santa Rosa
~-San Xavier
5-Pisinimo Clinic
6-MHU

7-6ells Inpatient
B-PHN (home visit)
9-Inpatient (other than
Sells)

WEEK GESTATION (cc 8-10)
I I
Inl
Provider tvoe
!n?
Pain
Dysuria
!o
' n..
Discharl7.e
"6\1ellinv."
O~
OJ;
Fetal Movement
Va~inal bleedlnp:
107
lIeadache
o~
I nq
Blurred vision
No problems
11o
BP diastolic
III 11
11 ? I I
WeiP:ht in Ibs.
p
FHR
FUNDUS
II"

EF'W

Edema
Reflexes
Position/Stat/Enp;
Urine protein
Urine Iducose
Het/llgb
Family llianninit
Breast feedinp:
Gen. counselinp:
Nutrition counselinp:
Strut. of risk or
prognosis
No. of inpatient days
PIH - dlast. BP

I

~

~

I

~

I

I

~

11

I

~

~

I

~

I

I

~

~

I

r 1

I

~

~

I

~

I

I I

I I

I I

I I
I I

t I
I I

I I
I I

I I

I I

I I
I I

I I

I I

I I

I I

I I
I I

I I
I I

I I
I I

I I
I I

I I
I I

I

I

I

I

I

I

I

I

I

I

I

I

I

I

I I

!I~

16
117
18
19
20
21
22
23
2..
25
26
1

I

27
28
29
30
31
32
33

•
(Reverse side of data collection form for prenatal care)

l'J

~

sn

fi!

Pisinimo

M(cc

1-1)

01 ' ,

14,

I

I

I

,

I

I

I

I~~l§T : : : : I

BIRTH DATE
(cc 28-33)

5'

YR.

-------r
( cc-1i(i:lil)
!Age

In

w!<s.{C(P,.IC))

Abdomen

~liS:.·':::==-·-

m

Pulscs

E3

cooraT~TOCI

MATERNAL DATA (RECORD TYPE

01: cc42-59)
Age

~~;~

B

'wbo~ ,_"o&Uon" ~

GJ!W/W
MO. DAY
YR.

~I[LLI. 11IITll.J~.~I.L~.LLi

-1'--1

_

t..:,..:;.~~""Providor tYP~.J.~~~E ..... _.. Dl •...
E_'!!'..L___
o~ -'
.liosQI~hr9.3t
_ _. oJ ....__...
~,!!!gslch~!t "
, ~ __..
._.
5
~~r~.'!.~.____
0. _ -..
....-_._

~o

Method of delivery:
1 Spont vag
2 Induced vag
3 Operative
4 Unknown
Nutrition/Feeding COUDS.
Inrant care counseling
Stmt. ot risk or
prognosis
Breast ted:
1 Yes
2 No
3 Unknown

BIRTH DATE
(cc 34-39)

I

:;~ng2

Ol-cc 8-21)

APGAR

w/l
I/w
00. DAY

COMM. OF RESIDENCE

NEWBORN DATA (RECORD TYPE
B.S (lbs-oz)
LenBth ~ inches)
APGAR 1

First

Last

I

~~c.

O~

_. ~7 .=~
0&

'.==-~

.

....•.• -

==.'

6

MHU

7 Sells Inpatient
8 PHN (bome visit)
9 Inpatient (otber tban Sells)

-_.,._-_1.__--,.-.---.-..

..
.,_ .

._._.
. .... 1.

.•. 1 ~---

.. - - - - . - 
._....._-_ ...•.. - •....•

"-~I--

"'F.-·I--'--

-'1-.-' -j-'
-:-.~.r--.1
-.-.---"-r'
-~·t-

.. ... C i J ' - " - - ' - "'\-'j"
--I
.~~t~~~:·(~~:.r_;~ _~J:= -= '.'~ ...,.~"._. --T"
~r= '..~'T"
T. .., .~:~r _
.. ~- .~.

~f.~d~~~rJ;, .... _,---

§.

UJ\

. ;:.I~

=..1=. _~L I-T~ ~J~~·r]--.- __ .1...' ·~.L.I _l

IS

Infant care counseling
p' ..-.-.-..--...- -------... I~ .. -.--' -..__...... _., - - - - - - . . - . 
Nutrition/Feeding COUDS
'~fi~-' .- -.'.- --------- ii -_. "-- ._-. ' - - - 
Family planning
.. ;;''''-e-----'
-i. --- '--- ----.
. discussed between
JI bas I ~.-'.
;; - - ._- -_.
delivery and 8 weeks
.RI,l.~ l
--------.--.. .._ ..
post partW1l
l!_lleUfe.D ._._.
,
. ~.~ .--'"
Method planned
91~t hl.s~or'i - ._ .. .-:- ..__.. ~I_.-_. .... .
1 IUD. 2 Pills. 3 Other~e~o'. hlst'?ry_ ..
1 1 .. ~_. • . -.
_... - .. ----. -_ .... --._- .-'-- - .•--- ...-...
Family Planning Started
.~!-ItrTTIon couns.· ..
l! - - ' ---- - - ' --._- ...---" .--.- - - ' '--'- . - Reroainded tree ot
.whloe core couos '._
11
pregnancy for 12 months
_N...,O...._or_I.:.:n:p_at_i:..e.:.n_t_d_a.:y..:.s-r_~lS=+-_l-f--L--+_L-I-...J.-+--I_I-..L.-+---L-jr-..L--t--L-jr-..l-i---L-1-..I...after delivery

0

No. or prenatal visits
made

L~

BO)

e e mOl/cment
'OrRlll 1 exam:';':·=---~l~ - _ .

0

Codes - Provider type/site
1 Sells OPD
2 MCR Clinic
3 Santa Rosa
4 San Xavier
5 Pisiniwo Clinic

. LLJ- LL~J.LlLLJd

c=l

Where delivered
1 Sells
~ Other
2 U or A
5 Unknown
3 HOllIe

r
(PATA

CC'L-l.-Ec.. Tlokl
INFANT

INSTf2L)ME't-l., r0li?.

CA£C")

i

I

Ip.

I

:PATI ENlS NAME

--:--==,.-----""7InM',--.---'"'""'ii'i"rui\iF-

LAST

FIRST

'MEDICAL RECORD NUMBER

. MIDDLE

---------

BIRTH DATE _ _--:..._
~__

SOCIAl SECURITY I

'COtflUNlTY OF RESIDENCE

_

. COMMUNITIES WHERE MEDICAL RECORDS HAVE BEEN, LOCATED
MEDICAL CARE EVALUATION PROJECT COHORT

_
.::.-

---:

_

.

o

LACE:RATIONS OF SCAlP AtlD EXTllE:1ITIES
MEDICAL RECORD AUDIT mSTRUHENT

Over IS yell'S

TARGET POPULATION:
PRIORITY GROUP:
STUDY PERIOD:
,1.

~1d

1 July 75 - I July 76

patient contact system for a laceration of scalp or extremity?
NO

YES

Provider

K)

PHH

'J>A
CHA - - -  _

2. Was all of the folloWing documented?

=
-

Time since laceration
Cause of laceration (blunt trauma. glass. dog bite. etc.)
Description of wound (,lean. deeP. jagged. etc.)
YES

3. Was the laceration on the scalp?

YES

NO

3.1 Was statement of underlying skull fracture made or an x-ray taken?
YES

NO

Go to question 15

4. WIS laceration stated as superficial?

YES

NO

4.1 Was there documentation of sensory. vascular. and motor function
distal to the la,erationl

YES

NO

5. Had patient received tetanus booster within 5 yeaTS?
YES

NO

5.1 Vas .Scc adsorbed tetanus toxoid given?

YES

80

6. Vas the wound suture<l?

YES
"6.1 Was patient seen within 5-15
NO

YES
Provf de /011
PHil

dayS

(for any reason)?

•

_

"

PA
QlA_-

6.2 Was

stat~nt

of wound healing made?

YES
7. Vas there evidence of wound infection within 2 weeles?

YES

tlO

-- ... .... 

I
.PATIENTS NAME --:--:-:::::-LAST

-:":';"=-;:--_

--".,.-=:;:-

FIRST

BIRTH DATE

'. ! Ii
--"

_

MIDDLE

.MEDICAL RECORD NUMBER

SOCIAL' SECURITY ,

COMMUNITY OF RESIDENCE

~

___

__

~

.CO!'MJNITlES WHERE MEDICAL RECORDS HAVE BEEN LOCATED

_

MEDICAL CARE EVALUATION PROJECT COHORT

_

STREPTOCOCCAL DISEASE
MEDICAL RECORD AUDIT INSTRUMENT
TARGET POPULATION: Over 6 years of age
STUDY PERIOD: 1 July 75 - 1 July 76
CHECK QUARTER RESEARCH WAS BEGUN: _

1 July 75. _1 Sept. 75. _1 Jan. 76; _

1 Mar.

(circle episode found)
1.0

Did patient contact system for
YES

~

pharnygitis? (1!J.lI:C==-1.'....3111l!£)
NO

Circle provider type

MD. PAl CHA. PHN. OTHER

_

2.0 Was a throat culture taken within 2 days?
YES
NO
2.1

Did patient receive antibiotic?
YES
NO

2.2 Was visit made 0-15 days after treatment?

YES

NO

2.3 Was there evidence that strep was addressed
as a prob1em?
YES
NO
2.4 Was throat culture taken?
YES
NO
3.0 Was culture positive?
YES

NO

Cou1dn 1 t find result at facility

4.0 Did the patient receive an antibiotic within 5 days of positive culture?
YES
NO
4.1 Was patient allergic to penicillin/ampicillin?
YES
NO
UNCERTAIN

4.2 Was antibiotic a) LA Bici11in 1.2 mu 1M or 600.000 mu for
children less than 60 lbs or 9 years or
less in age
b} Oral pen x10 day
c Erythromycin Q10 xl0 days
d Other
5.0 Was a visit made within 21 days after treatment started?
YES
NO
6.0 Was strep management a purpose of the Visit?

YES

NO

YES

NO

8.0 Was culture positive?
YES

NO

7.0 Was culture taken?

Couldn't find result at facility

. PATIENTS NA:·\E

-.".==-
FIRST

LAST
:MEDlCAL RECORD NUMBER

-:-:-;=-;=--_

CQt.:-rutHTIES

~lHERE

BIRTH DATE

_

MIDDLE
SOCIAL·SECURITY :

:COf1HUNITY OF RESIDENCE
I

!:

I

--=--==-

___

_

HEDlCAL RECORDS HAVE BEEn LOCATED

_

MEDICAL CARE EVALUATION PROJECT COHORT

__

~

i

r
RHEUHATI C FEVER

MEDICAl RECORD AUDIT INSTRUMENT
TARGET

POPULATIor~:

:

All patients with rheumatic

PATIBITS AGE:

fever who should be on
prophylaxis as per registry

~lHEN

_

LAST EPISODE

OF ARF: -===~_
~lonth/Year

NUMBER OF EPISODES

ARF:

_

Significant cardiac sequela
1.0 Was patient treated prohylactica11y with LA bici11in 1.2 mu 1M?

YES

.:a..

NO

&

2.0 Was patient allergic to penicillin/ampicillin?

YES

NO - go directly to question 3.1

3.0 Was patient treated with either (Circle appropriate)
I'
t"

,I

.

Su1fadi azi ne
Erthromycin

!i
~
i

1 gram g.d. (0.5 gr. under 60 lb.)
250 mg per QID

YES

i

HO

\

Coverage
Coverage
Coverage
Coverage

LA Bieil1in:

oral penicillin: 
Erythromycin:
oral SuI fadiazine:

rate
__
rate
__
rate
rate ---------

4.0 Was pati-ent off prophylaxis 4 or more continuous weeks?

NO

YES

5.0 Did patient make contact with system while off prohylaxis?

YES
Prov; del type

5

'NO
PHN

1:1
12
14 _'

U

IE

.,

15

..r:u

18
13

22·
24
2&
H

25

2!
3:l

3Q

;:.2

C!e

CHA
,PA

22

2&

25
23
;J

S:;'
1
&

6

a

YES
;OI\TE
" .

, flO

~

•

19

21

::z

l~

12
1~

'6

n

i':

An
2
4

6

a

lJ
.12 '
Ie
15

la
2"
22

lC

os
.~

»

.1-\:'1
2
4
6

IE

2
&
6

7.0 Did patient have a recurrence of ARF during audit year?

25
28

!!

OCT

NO

n
2Z
n

1&
I!

t

YES

~!

II

10·
12

··u

30

6.0 Did provider renew prophylaxis?

a

10
12

2!
21

_

2

.4
6

,~

13

2'l

30

1C
~3

12
14
15
18

2&

:J'
12

15

t

1:1

23·

l:l
12

24

_

6

a

t

III
12

2:
~jI)

2
&

6

~.

3.1, What was method of prophylaxis?

1'..;Jl

&

2
&

\

If
If
If
If

=:1
2

2

2~

24

26

..

13

,-...

.13
<-

za

lS
2S
3:l

Fa
2

--2

&

6

4
Ii

13
12

Ie
12
1C

3:l

a

~

15

-.

e

is

II

II

18

Z'
2t
7:4
26
%8
JO

2:)

2:)

2!
lC
26

22

~

JO

:.1.
25

il
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Fe-DEFICIEOCY ANfMIA
(~iagnosis

and Management)

SITE

-------
(h)

SIUDY

POPlP....ATION (g)

(i)

(j)

(k)

Fe-DEFICIENCY ANEMIA
(Diagnosis and Management)
(Continued)

(1)

(m)

(n)

(0)

.......
.. f

,.

..;"

SITB:.....-

:I
·j

.

URINARY mer INFECfION
(Diagnosis and Management) ,

_

(h)

, Ij

(i)

. (j)

(k)
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I
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~
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, S1UDY
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;
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partial
work-up

.

URINARY 'l'RACf INFECTION
(ContiIUlect)

'~

(m)

(1)

(0)

(n)

i

I
J

(
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\
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HYPERTENSIOO - SCREENING
SITH'-

_

,
\

(e)

(b)

(d)

SlUDY

. roPULATIW (a)

,.

.
.r

-l

"",

.
"

._--_ _--_._..

.

.

~----I--·--------

VISUAL AOJITY - SCREENING AND REFERRAL

(e)

(P)

snJDy
POIlJLATI<W (a)

1-

(li)

(e)

(f)

